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Chapter 1 
 
 
Introduction 
 
1.1 Membrane Proteins 
Membrane proteins, while often difficult to study biochemically, play a crucial role in the 
dynamic and diverse cell membrane. Of all human genes, about ⅓ of these genes 
encode for membrane proteins [1] and of this subset only 3% have known 3D structures 
[2]. While many scientists are interested in studying membrane proteins as 
pharmacological targets, they present several challenges that have slowed their 
characterization. One of the main challenges is that membrane proteins often express in 
very low levels, making them difficult to study biochemically. Another factor relates to 
the fact that these proteins have both hydrophobic and hydrophilic regions that need to 
be satisfied by the surrounding solvent. This requires either studying the protein in the 
native membrane or isolation into a model membrane environment such as bilayered 
lipid vesicles or micelles that will satisfy both the hydrophobic transmembrane region 
and also its hydrophilic loops [3]. Solubilizing proteins into membrane mimetics like 
micelles can be a valuable tool when subjecting membrane proteins for biochemical and 
structural studies, which can provide the basis for better understanding membrane 
proteins.  
 
 
1.2 Potassium Channels 
Potassium channels are a class of integral membrane proteins that exist in virtually all 
species in both excitable and non-excitable cells [4]. This potassium channels are 
responsible for transporting specifically K+ ions from in the extracellular space to the 
intercellular space separated by the plasma membrane. Potassium channels are broken 
down into 3 classifications based on the channels structure and functions. One class is 
the inward rectifying channel (Kir) that contains 2 transmembrane helices and is regulated 
by intercellular factors. Another is the tandem-pore domain channel (K2P) that consist of 
  2 
4 transmembrane helices. Lastly is the voltage-gated Kv channel which consist of 6 
transmembrane helices and is activated by the change in membrane depolarization [5, 6] 
The classes are divided into 2 parts: pore-forming and regulatory. Pore-forming domain 
allows the passage of K+ ions through the plasma membrane. This domain is highly 
conserved throughout most potassium channels and many scientist have created models 
of this domain [6]. The regulator domain is structurally different throughout the potassium 
channels categories but its role is to detect diverse stimuli within the cell like membrane 
potential. This regulator domain is often what differentiate K+ channels [6].  
 
One element that connects most potassium channels is the highly conserved pore domain 
and how it functions. The pore domain consist of 2 alpha helical transmembrane regions 
that are connected by a flexible unstructured region, the p-loop. The P-loop  acts as the 
selectivity filter and has a highly conserved TVGYG sequence that plays a critical role in 
selectively allowing potassium ions to pass through and prevents passage for  all other 
ions.  
 
This selectivity filter contains 4 K+ binding sites (S1-S4) that are evenly spaces. These 
binding sites are formed by making a “cage” of 8 carbonyl O2 ions from the TVGYG 
conserved region. In order of K+ ions to pass through the small filter water molecules must 
be removed. The carbonyl O2 of the TVGYG motif satisfy the energetic cost associated 
with the dehydration of the K+ ions allowing them to pass through the selective filter where 
they are rehydrated when entering the water filled vestibule (Figure 1). Ions like Na+ are 
not able to pass through due to the smaller size of Na+ that does not bond strongly enough 
to the TVGYG motif [7, 8]. The MacKinnon group showed that only 2 potassium ions can 
occupy the 4 S1-S4 binding sites at a time, either at the S1 and S3 sites or the S2 and 
S4 sites. When concentration is high, ions move in an orchestrated manner from 1,3 -
configuration to 2,4- configurations [8-11] (Figure 1). After rehydration in the water filled 
core, the K+ ion wait for the channel to open before it enters into the intracellular 
compartment.  
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Figure 1: Potassium Ion Flow Into Channel 
This figure shows the transmembrane channel regions of potassium channel KcsA. Part a shows the 
experimentally determined structure of the pore region of KcsA. The magenta helix represents the outer 
helix. The pore helix is in blue, the inner helix is orange, and the selectivity filter is in yellow. K+ ions are 
represented in purple and water molecules in red in panels a, b, and c. Panel a shows K+ ions being 
dehydrated by the selectivity filter and rehydrated in the channel pore. Panel b and c  show the 1,3- and 
2,4-configuration of potassium passing through the TVGYG selectivity filter. Figure from reference 6. 
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1.3 Kv Voltage-Gated Channels 
Kv voltage-gated channels are a diverse group that is split into 12 main families (K1-K12) 
[12] and contribute to several cellular processes from excitable cells, apoptosis [13], cell 
growth and differentiation [14], and cardiac activity [15]. Kv channels are unique from 
other potassium channels in that they are activated differently and have a more 
sophisticated transmembrane topology compared to other K+ channels. When compared 
to KcsA channels, Kv channels are activated by membrane voltage creating a depolarized 
cell while KcsA is activated by lowered pH [16, 17] and Kv has a 6 transmembrane 
topology while KcsA has a more simple 2 transmembrane topology [18]. The 6 
transmembrane helices single unit form a tetramer to form the full channel with two 
independent domains. Helices S1-S4 make up the voltage sensing domain (VSD) and 
undergoes conformational changes when charges residues on the S4 helix detect 
changes in membrane potential.  Helices S5 and S6 make up the pore domain (PD) that 
allows K+ ions to flow through. Like other potassium channels, S5 and S6 are connected 
by a p-loop or selectivity filter that is discussed in more detail in section 1.2 (Figure 2). 
The VSD and the pore-domain are connected by an S4-S5 linker that plays an important 
role in channel opening. 
 
 
 
Figure 2: Topology of Kv potassium channel single alpha unit. 
This figure shows the topology of a single alpha unit of a Kv channel where S1-S4 make up the voltage 
sensor domain and S5 and S6 make up the pore domain. S5 and S6 are connected by the p-loop containing 
the GYG motif that coordinates K+ ions and provides selectivity for the channel. S6 helix displays the PVP 
conserved motif that leads to a kinked S6 helix. Figure from reference 19. 
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Models and simulation of an isolated S6 helix suggest that the helix is kinked right at the 
highly conserved PVP motif and allows this hinge region to undergo dynamic changes  
[20-22]. Experimental studies have shown that, while less flexible, S6 PVP region still 
remains kinked when in its tetrameric form [23, 24] and may be important for gating. The 
S4 helix, a part of the S1-S4 VSD, contains 4 positively evenly spaced charged Arg 
residues. In response to changes in the action potential, S4 helix undergoes an rotational 
and upwards movements. This S4 movement causes conformational changes within the 
entire VSD. This conformational change of the VSD is connected to the pore domain  and 
leads to channel open. Upon depolarization, all Kv channels transition from a closed, to 
intermediate, then open conformational state where ions are only conducted in the open 
state. KCNQ1, the first of 5 discovered in the KCNQ subfamily, is unique from other Kv 
channel and within its KCNQ subfamily because it has the ability to be voltage dependent 
and voltage independent.  
 
 
1.4 KCNQ1 Function and Relation to Human Disease  
 
KCNQ1 (Q1), a member of the Kv channel family, is a 676 amino acid voltage-gated 
potassium channel that forms functional homotetramers in the plasma membranes of 
vertebrates. It is expressed in several tissues throughout the body including the heart, 
lungs, and intestine. Mutations in this channel can have a significant and distinct effect 
on human health. A unique property of the normally voltage-gated KCNQ potassium 
channel family is that, when associated with certain ancillary proteins, they can be 
activated independent of changes in transmembrane voltage and thus can serve as  
“leak” channels [25]. Because Q1 is widely expressed, both gain-of-function and loss-of-
function mutations in the Q1 channel or its ancillary proteins can lead to health issues 
such as atrial fibrillation [26], deafness [27] and cardiac arrhythmias, such as long QT 
syndrome, leading to cardiac arrest. More mild health issues like poor balance and 
abnormalities in the inner ear [28] and intestines [29] have also been noticed in KCNQ1 
mutant mice (Figure 3). The fascinating relationships between Q1 function and its binding 
partners and their implications for human health have made this channel and its binding 
partners the targets of many studies. 
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Figure 3: Mutations In KCNQ1 That Lead To Human Disease. 
This figure depicts several mutations in KCNQ1 that lead to human disease. Many of these mutations are 
loss-of-function mutations (red sites), while fewer are gain-of-function mutations (blue sites). These 
mutations are spread throughout both the voltage-sensor (S1-S4) and pore domain and cause disease with 
varying degrees of severity.  
 
 
Q1 has six transmembrane segments, with the first four (S1-S4) comprising the voltage 
sensor domain and the last two (S5, S6) contributing to the pore that forms the ion 
conduction pathway (Figure 3, Figure 4). When in its functional, homotetrameric form, the 
VSD domains form 4 nodules on the outside of the pore domain. The transmembrane S4 
helix of the voltage sensory domain (S1-S4) contains four positively charged residues 
that can sense the electrical potential of the membrane and undergo a conformational 
change from its resting configuration to the activated state when the transmembrane 
electrical potential transitions from a negative to a positive value during the action 
potential. The activation of the voltage sensor domain is coupled via the S4-S5 connector 
to the opening of the channel gate in the pore domain, resulting in activation of potassium 
ion conduction by the channel.  The pore domain includes a “P-loop” between S5 and S6 
helices that provides the K+ ion selectivity of the channel [30, 31] (Figure  4). 
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Figure 4: Schematic of KCNQ1  
(Left) S1-S4 make up the voltage sensor domain while S5 and S6 make up the pore domain. These two 
domains are coupled by the S4-S5 linker. S4 has multiple positive charges that sense the voltage, triggering 
channel opening. (Right) This panel shows the channel homotetramer with one of Q1’s binding partners, 
KCNE1, bound to the clefts between two VSD. The figure is from reference 32. 
 
 
1.5 KCNE Family 
 
Under physiological conditions, Q1 can be modulated by any member of the KCNE family, 
with KCNE1 (E1) and KCNE3 (E3)  being the most well-studied. Members of the KCNE 
family have a single TM alpha helix and bind homotetrameric Q1 to form a complex, 
possibly with a 4:2 KCNQ1:KCNE subunit stoichiometry [33]. While some studies suggest 
the KCNQ1:KCNE complex forms in a 4:4 ratio [34, 35], several other studies observed 
steric clashes in a 4:4 complex and propose an alternative 4:2 KCNQ1:KCNE ratio [36-
39]. It is believed that the KCNE site is located between the VSD nodules right above the 
S4-S5 linker [40, 41, 42]. While E1 and E3 are homologs, their tissue localization and 
channel modulatory effects are strikingly distinct. The Q1/E1 complex is expressed in 
cardiomyocytes where the complex results in delayed channel activation and an increase 
open state conductivity (Figure 5). The Q1/E1 complex provides the repolarizing IKs 
current of the cardiac action potential of cardiomyocytes [43, 44] and is essential for heart 
muscle contraction. On the other hand, the Q1/E3 complex is found in epithelial cells of 
the colon, stomach, and kidney, where association of E3 with Q1 leads to a constitutively 
active “leak” channel that is critical for the secretion of potassium and chloride ions in 
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epithelial cell fluid and salt homeostasis [30, 31, 45] (Figure 5). While less studied, KCNE4 
is mainly expressed in the uterus, where it binds to the Q1 channel to inhibit the channel 
from opening when in the presence of calmodulin [46] 
 
 
 
Figure 5: Conductance of KCNQ1 Channel When Bound to Ancillary Subunits 
This figure shows the conductance of the KCNQ1 channel in the absence of ancillary subunits and when 
bound to KCNE1, KCNE3, and KCNE4. (a) shows a homotetrameric KCNQ1 channel in the absence of 
any ancillary proteins. This figure shows a channel that opens rapidly but has very low conductance. (b) 
depicts the current from the KCNQ1/KCNE1 complex. Much higher conductance can be seen in the 
channel, but also delayed activation. (c) shows current for the KCNQ1/KCNE3 complex, exhibiting 
increased conductivity and constitutive activation: “leak” channel behavior. (d) KCNQ1/KCNE4 is shown to 
be a completely inhibited channel. This figure is adapted from reference 42. 
 
 
1.6 Mechanism of KCNQ1 Opening 
 
Our current understanding of how the Q1 channel opens begins with the S4 helix. The 
positively charged residues on S4 sense the hyperpolarized potential of the cell and 
undergo an upward rotational conformational change. The helix movement causes a 
lateral pull on the S4-S5 linker that couples the VSD and pore domain via the S6 helix 
and thus leads to channel opening.  The E1 TM C-terminal and N-terminal domains have 
extensive interactions with the Q1 channel and this may play a critical role in the delayed 
activation of the channel. The critical E1 functional residues T58 and L59 are thought to 
interact with S338, F339, and F340 of S6 in Q1 [32, 47, 48, 41]. E1 has been proposed 
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to sit between the VSD nodules right on top of the S4-S5 linker [41, 42] and is believed 
to impede channel opening but not the S4 movement. The N-terminal end of the E1 TM 
domain interacts with residues at the top of the Q1 S1 helix in a “gain-of-function cleft” 
while the C-terminal end of E1, specifically H73, S74, and D76, interacts with residue 
H363 in the S6 Q1 helix, and is believed to contribute to the channel’s increased 
conductivity upon opening, as well as to delayed opening [46]. At high transmembrane 
voltage potentials, the S4 helix senses the elevated voltage and undergoes a 
conformational and position change that leads to an intermediate, yet closed channel 
state under conditions where E1 is bound and inhibits the coupling of the S4 helix to the 
S6 helix of the pore domain. The channel will not open and conduct completely until all 
S4 helices are in the fully active conformation [53, 47, 42] (Figure 6). 
 
 
 
Figure 6: Models of KCNQ1 Bound to KCNE1 in Open and Closed Conformation 
This figure shows models of the open (left panel) and closed (right panel) states of the homotetrameric 
KCNQ1 channel bound to KCNE1. The left panel shows E1 sitting on top of the gating S4-S5 linker in the 
closed position. During full activation, the E1 protein rotates and pulls away for the S4-S5 linker and 
associates with a series of residues that, when mutated, lead to gain of function of Q1. This is called the 
gain of function cleft that is located between the sensor and pore domains. 
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E3 has 2 critical acidic residues juxtamembrane at the N-terminal end, D54 and D55, that 
contain electrostatic interaction with Q1 residue R237 in the S4 helix. This interaction 
promotes to the channel’s voltage independent and stabilizes the channel in a 
constitutively open state [44]. E3 also makes extensive contact with the S4-S5 linker [53, 
47]. While the structures of E1 and E3 TM regions exhibit curved structures, they interact 
with Q1 through different mechanisms. Their distinct interactions lead to E1 contributing 
to both the S4 helix movement and channel gating, while E3 primarily affect the S4 
movement [47]. 
 
 
1.7 KCNE1 and KCNE3 Functional Regions 
 
Studies have shown the transmembrane region of both E1 and E3 is necessary for their 
unique functions when bound to Q1. More specifically, amino acids F57, T58, and L59 of 
E1 and T71, V72, and G73 of E3, both in the center of their respective TM helices, are 
critical to determining their functional differences. Studies indicate that when these sites 
in E1 are swapped in the corresponding wild type sites in E3 to generate the E3TVG→FTL 
mutant, this modulates Q1 in a manner that closely resembles modulation by wild type 
E1. In particular, delayed Q1 channel activation is induced by binding of the E3TVG→FTL 
mutant to the channel, which now affects both Q1 channel S4 movement and gating. 
Conversely, swapping in the E3 triplet motif into E1 to generate E1FTL→TVG leads to E3-
like constitutive activation of the Q1 channel [54, 55; 47] (Figure 7). 
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Figure 7: Electrophysiology of KCNE1 and KCNE3 With Select Residues Switched 
This figure represents the transmembrane regions of KCNE3 with open circles and KCNE1 with closed 
black circles. The left panel indicates a majority KCNE1 with 3 TM KCNE3 residues that behaves similarly 
to KCNE3 as a constitutively active channel. The right panel shows a majority KCNE3 protein with 3 
residues inserted from KCNE1. This mutation leads to a KCNE3 channel that exhibits delayed activation, 
similar to KCNE1. This figure was adapted from reference 54 and 55. 
 
 
It is clear from these results that the triplet motifs located near the middle of the E1 and 
E3 TM segments are critical to defining how E1 and E3 exert their distinct effects on Q1 
function. However, little information is known about how these motifs alter the structures 
and/or dynamics of each KCNE subunit or how these changes result in altered channel 
interaction and functional modulation. I hypothesize that the TVG motif leads to a 
structural change of the transmembrane helix of KCNE1 which may lead to E1FTL→TVG 
interacting with Q1 in a different fashion that E1. 
 
This study details the cloning and subsequent purification of a uniform isotopically labeled 
E1FTL→TVG to make NMR resonance assignments by using a suite of 3D experiments and 
specific isotopic labeling techniques. The chemical shift data from these assignments 
were used to determine the secondary structure of the protein, providing the basis for 
comparison to both wild type E1 and E3. With assignments in hand, it is possible to move 
forward with other NMR-based structural experiments to better elucidate how the 
E1FTL→TVG mutation differs from wild type E1 and E3. These NMR-based structural 
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experiments give way to determine the structure of E1FTL→TVG to provide additional insight 
and to provide the basis for possible docking studies to the Q1 channel. 
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Chapter 2 
 
 
 
Methods and Materials   
 
 
2.1 Reagents and Materials 
 
The QuickChange II site-directed mutagenesis kit and QIAprep spin mini-prep kit were 
purchased from Qiagen (Foster City, CA). XL1-Blue, BL21(DE3) CodonPlus PR, and 
CT19 E coli competent cells were prepared at the Vanderbilt University MegaLab 
(Nashville, TN). MEM (100x) vitamins were purchased from Sigma-Aldrich (St. Louis, 
MO). (LPMG detergent was purchased from Anatrace (Maumee, OH). Ni-NTA was 
purchased from ThermoFisher Scientific (Waltham, MA). Precast SDS-PAGE gels were 
purchased from ThermoFisher Scientific (Waltham, MA). Analytical grade imidazole was 
purchased from Sigma-Aldrich (St. Louis, MO). Protein markers for SDS PAGE gels 
were purchased from ThermoFisher Scientific (Waltham, MA). The 800MHz and 
900MHz NMR spectrometers used were Bruker Avance III. 
 
 
2.2 Cloning of KCNE1FTL⇢TVG (E1FTL⇢TVG) 
 
cDNA encoding full-length human E1FTL⇢TVG was created from the wild type E1 template 
using the QuickChange mutagenesis kit from Qiagen consisting of Pfu polymerase and 
Dpn1, and cloned into a pET16b expression vector according to a published protocol [56]. 
The E1FTL⇢TVG mutant construct employed in this study includes not only the wild type E1 
residues 71-73 (FTL) replaced with the corresponding residues of E3 (TVG), but also 
includes mutation of the single wild type cysteine (residue 106) to serine and an N-
terminal HHHHHHG- purification tag (136 residues, with tag). The DNA was then 
transformed into XL1-Blue competent cells and plated on an agar gel plate with 
appropriate antibiotics and incubated overnight at 37°C. Single colonies were picked and 
used to inoculate LB medium for 6-8 hours at 37°C before being mini-prepped using a 
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Qiagen QIAprep Spin kit. The mini-prepped samples were submitted for sequencing to 
confirm that the mutations were correctly inserted. 
 
 
2.3 Overexpression of KCNE1FTL⇢TVG 
 
The vector encoding His6-E1FTL⇢TVG was transformed into BL21(DE3) CodonPlus RP 
competent cells using a heat-shock technique, and the cells were plated on agar with the 
appropriate antibiotics overnight at 37°C. Single colonies were picked and added to LB 
medium with appropriate antibiotics, then agitated at 37°C for 6-8 hours or until solutions 
were turbid. 2-3 mL of this starter culture was added to 1L of 15N-M9 media (0.1 mM 
CaCl2, 1 mM MgSO4, 0.4% glucose, 10 mL 1X MEM vitamins, 100ug/ml of ampicillin, and 
34 ug/ml of chloramphenicol). This was followed by rotary shaking at 25°C for 16-18 hours 
until the optical density (OD600) was between 0.7 and 1.0. Cell expression was induced 
using 1 mM IPTG, followed by continued rotary shaking at 37°C for 6 hours. The cells 
expressing recombinant E1FTL⇢TVG were harvested at 6,000 X g in 4°C, flash frozen, and 
stored at -80°C until ready for purification. 
 
 
2.4 Purification of E1FTL⇢TVG into LMPG Detergent Micelles 
 
Because E1FTL⇢TVG and wild-type E1 are membrane proteins, they need a membrane 
mimetic to aid in purification and proper folding of the protein. Various detergent 
micelles and bicelle conditions were tested, and lyso-myristoylphosphatidylglycerol 
(LMPG) micelles proved to yield an NMR spectrum that was well dispersed [56] 
indicating that it was well folded under these micelle conditions. LMPG micelles were 
used throughout the entire project unless otherwise stated. 
 
 
2.4.1 Solubilizing Inclusion Bodies with KCNE1FTL⇢TVG 
 
Frozen cell pellets containing overexpressed E1 were thawed and resuspended in lysis 
buffer (75 mM Tris-base, 300 mM NaCl, 0.2 mM EDTA, pH 7.8) at 20 mL per gram of 
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cell pellet. Added to the dissolved cell pellets were 2 uL of LDR solution (100mg/mL 
lysozyme, 10 mg/ml DNase, 10 mg/mL RNase, 10% glycerol) per mL of lysis buffer. To 
complete cell lysis conditions, the protease inhibitor PMSF was added to a final 
concentration of 1 mM and magnesium acetate to a final concentration of 5 mM. This 
solution was tumbled for 30 minutes at 4°C. The solution was then probe-sonicated on 
ice for five minutes with an alternating 5-second pulse and 5-second rest cycles. The 
lysed cells were centrifuged for 20 minutes at 20,000 x g at 4°C. The supernatant was 
discarded, and the inclusion body pellet was homogenized in lysis buffer. The 
homogenized pellet was sonicated on ice and centrifuged using the same conditions as 
listed above, before being resuspended in 10mL of an 8M urea and 0.2% lauroyl 
sarcosine solution per gram of wet cells. This solution was tumbled overnight at 4°C.  
 
 
2.4.2 Purification and Buffer Exchange of  E1FTL⇢TVG 
 
The dissolved inclusion bodies were centrifuged at 30,000 x g for 45 minutes at 4°C to 
remove debris. This supernatant was mixed with 1.2 mL of Ni-NTA resin per gram of wet 
cell pellet and tumbled at 4°C for 1 hour. The solution was transferred to a gravity-flow 
column, allowing the supernatant to pass through, leaving the resin with bound protein.  
The resin was washed with 10 column volumes of a wash buffer (20 mM tris, pH 7.8, 150 
mM NaCl, 0.2% lauroyl sarcosine) to remove urea. The resin was then washed with 10 
column volumes of a buffer exchange solution (20 mM tris, pH 7.8, 150 mM NaCl, 30 mM 
imidazole, 0.2% LMPG) to exchange in the non-denaturing detergent LMPG and to elute 
loosely bound impurities. The protein was eluted with 300 mM analytical grade imidazole 
at pH 7.8 with 0.2% LMPG to a final volume of 10ml. The protein concentration was 
determined by measuring light absorption at 280nm using an extinction coefficient of 1.29 
OD per mg/mL per cm. An SDS-PAGE gel was used to assess if the target protein was 
present, the presence of impurities in the sample, the presence of oligomers, and the 
presence of degradation or cleavage products. By SDS-PAGE E1FTL⇢TVG exhibited an 
apparent molecular weight of 15.4 kDa for. This purification approach yielded 
approximately 2.5 mg of pure protein per liter of medium. 
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2.4.3 SDS Polyacrylamide Gel Electrophoresis (SDS-PAGE) of E1FTL⇢TVG 
 
10% precast Tris-SDS PAGE gels were loaded with 1:4 ratio of diluted KCNE1FTL⇢TVG to 
loading dye. The gel was run at 100V in a 1X running buffer and included a lane with 
SeeBlue prestained protein marker used to evaluate the apparent molecular weight of the 
protein. Following electrophoresis, the gel was removed from the casket and washed with 
milli-Q water, then heated using a microwave for 45 seconds, then put on a slow rotary 
shaker for 5 minutes. Water was removed from the gel and replaced with Simply Blue 
stain, heated in a microwave for 45 seconds, then incubated using rotary shaking until 
protein bands appeared. Distaining of the gel was done by removing the stain solution 
and replacing it with dH2O and 1-2 Kimwipes until the blue stain is removed and bands 
are clearly observed on the gel. Sample bands were compared to the SeeBlue prestained 
marker to determine the apparent molecular weight. 
 
 
2.5 NMR Sample Preparation and NMR Spectroscopy 
 
Uniformly 15N-labeled His6-E1FTL⇢TVG was exchanged from the elution buffer listed above 
into an NMR buffer (10% D2O, 50 mM imidazole, 50 mM NaCl, 2 mM EDTA, 0.05% 
LMPG, pH 6.5) using a 10 kDa molecular weight cut-off Amicon Ultra-15 centrifugal filter. 
Using the same centrifugal filter method, E1FTL⇢TVG was concentrated to 1 mM, and 200 
uL was carefully transferred to a 5 mm NMR tube. Using a Bruker 800 MHz or 900 MHz 
spectrometer, 2-dimensional 1H,15N-TROSY(transverse relaxation-optimized 
spectroscopy)  spectra of U-15N- E1FTL⇢TVG were collected at 45°C. 256 x 512 points were 
collected in the 15N dimension and 1H dimension, respectively, and the spectra were 
processed in TopSpin and analyzed using NMRFAM-Sparky from the National Magnetic 
Resonance Facility at the University of Wisconsin-Madison. 
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2.6 Isotopic Labeling of E1FTL⇢TVG and NMR Resonance Assignments 
 
All experiments were conducted using either an 800MHz or 900 MHz Bruker Avance III 
NMR spectrometer using a TROSY or HSQC based pulse sequences. The spectra from 
these experiments were processed using TopSpin and analyzed using NMRFAM-Sparky.  
 
 
2.6.1 Uniformly  13C,15N, isotopically-labeled E1FTL⇢TVG 
 
Uniformly 13C,15N, isotopically-labeled E1FTL⇢TVG was prepared and purified using the 
methods listed above, with the addition of 4 g of 13C6-glucose instead of 2 12C-glucose to 
the minimal medium.  
 
 
2.6.2 Inverse Labeling of E1FTL⇢TVG 
 
Inverse labeling (unlabeled Thr or Ser in otherwise 15N-labeled protein) of E1FTL⇢TVG was 
expressed in15N-enriched-M9 medium with the addition of 1g of an unlabeled 14N amino 
acid of choice. Inverse labeled E1FTL⇢TVG  was purified using the standard method. 
 
 
2.6.3 Specific Amino Acid Labeling of E1FTL⇢TVG 
 
To express protein labeled with a specific 15N amino acid (15N-labeled Ala, Val, Phe, Leu, 
Met, Ile, or Thr in otherwise unlabeled protein), CT19 cells containing unlabeled-
E1FTL⇢TVG were grown in LB medium until OD600 reached 0.5, then gently spun down and 
washed. Washed cell pellets were resuspended in unlabeled-M9 medium with specific 
antibiotics, 0.5g of each of the 7 unlabeled amino acids (Val, Ala, Phe, Leu, Ile, Tyr, Asp), 
0.1g of unlabeled Trp and 0.5g of the specific 15N-labeled amino acid of choice (per liter 
of culture). When 15N labeling one of the 7 unlabeled amino acids listed above, the 
unlabeled amino acid was replaced with the 15N-labeled version at 0.5g. These cells were 
induced, harvested, and the specifically 15N-labeled E1FTL⇢TVG protein was purified using 
the methods listed above.  
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2.6.4 3D Experiments for Assignments, Single Amino Acid Labeling, and Inverse 
Labeling 
 
Uniformly 13C,15N, isotopically-labeled of E1FTL⇢TVG was prepared and purified using the 
methods listed above, with the addition of 4 g of 13C6-glucose instead of 2 g of 12C-glucose 
to the minimal medium. To make resonance assignments, the following experiments were 
used: 3D TROSY-based pulse sequences (HNCACB, HNCO, HNCA, HNCACO, HNCB), 
inverse labeling (unlabeled Thr or Ser in otherwise 15N-labeled protein), and specific 
amino acid labeling (15N-labeled Ala, Val, Phe, Leu, Met, Ile, or Thr in otherwise unlabeled 
protein).  
 
 
2.7 T1 and T2 15N Relaxation Measurements 
 
Uniformly 15N-labeled E1FTL⇢TVG was expressed and purified as described above. The 
same sample was used for both T1 and T2 experiments, which were performed on a 
Bruker 900MHz spectrometer at 323 K. 2D inversion recovery spectra used for 
determining T1 values were collected using a TROSY-based pulse sequence. 
Relaxation delay times were 15, 30, 50, 100, 200, 400, 800, 1200, 1600, 2000, and 
4000 ms. T2 correlation spectra were collected using a 2D TROSY version of the Carr-
Purcell-Mieboom-Gill sequence using delay times of 3.38, 8.48, 16.96, 33.92, 50.88, 
67.84, 84.80, 101.76, 135.86, and 169.60 ms. The delay time between scans used in 
both relaxation experiments was 3.6 ms.  
 
 
2.8 Gd(III)-diethylenetriaminepentaacetic acid (Gd-DTPA) and 16-doxyl-stearic 
acid (16-DSA) 
 
To make matched E1FTL⇢TVG NMR samples for 16-DSA, Gd-DTPA, and a reference 
sample, 2L of cells were grown and purified as a single sample using the protocol 
described above. This was split into 3 samples; the paramagnet-free reference, the 16-
DSA-containing sample, and the Gd-DTPA-containing sample. All samples were in 
NMR buffer at pH 6.5 and contained 0.5 mM of U-15N-labeled E1FTL⇢TVG and an LMPG 
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concentration of 8%. 200ul of this sample were placed in a 3 mm NMR tube and then 
subjected to NMR spectroscopy on a Bruker 900 MHz spectrometer at 323 K. 
 
The aqueous probe, Gd-DTPA, was added to a final concentration of 20 mM from a 
2.5mg/ml stock to a sample containing 0.5 mM  E1FTL⇢TVG and 10 mM EDTA in NMR 
buffer. Both this sample and the reference sample were incubated for 1 hour at room 
temperature then 5 minutes at 323K in the spectrometer before running 2D 1H,15N- 
TROSY experiments. The spectrum from the Gd-DTPA-containing sample was 
superimposed on the matched reference sample (collected with the exact same spectral 
acquisition parameters) for comparison. This data was analyzed by measuring the 
intensity ratio for each peak between the probe-containing sample and the reference 
sample.    
 
To make the lipophilic probe stock sample, 16-DSA was dissolved in methanol to a final 
concentration of 2.5mg/ml. 113uL of the stock was added to an empty Eppendorf tube 
and the methanol was evaporated by gently blowing nitrogen over the sample until a 
thin residue of 16-DSA was left. 200uL of  E1FTL⇢TVG in NMR buffer with 8% LMPG was 
then added to solubilize the dried 16-DSA in the 1.5ml Eppendorf, and the sample was 
incubated for 16 to 18 hours at 37°C, then transferred to a 3 mm NMR tube. This 
sample was used to collect a 2D 1H,15N-TROSY spectrum that was compared to that of 
the matched reference sample using the same method as used for the Gd-DTPA 
experiment. 
 
 
2.9. Clean-EX PM of E1FTL⇢TVG  and E1 Wild-type 
 
15N-E1FTL⇢TVG and 15N-E1 were both expressed and purified using the standard 
methods described above and buffer-exchanged into NMR buffer. 2D CLEANEX-PM 
HSQC pulse sequences were run at 323K on both samples with exchange delays of 
25ms and 100ms on a 900MHz spectrometer. Peak intensities in the Clean-EX spectra 
were quantitated and compared to the peak intensities of the reference HSCQ [57, 58]. 
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Chapter 3 
 
 
Results of Cloning, Characterization, and Assignments of KCNE1FTL⇢TVG 
 
3.1 Introduction  
  
Membrane proteins make up approximately 1/3 of all proteins and many are related to 
human health, disease, and even cancer, yet they can often be challenging to study 
biochemically and structurally, in part because they are hard to overexpress and purify 
[2, 59, 60]. Many biochemists study membrane proteins produced using E. coli 
overexpression systems. E. coli overexpression methods can be inexpensive, robust, 
and sometimes allow large protein yields and uniform isotopic labeling of membrane 
protein.  This previously proved to be the case for wild-type human KCNE1 [56] and 
other proteins within our lab including the unique KCNE1/KCNE3 mutant used for this 
project. 
 
It is known that switching transmembrane residues FTL of KCNE1 (E1) and TVG of 
KNCE3 (E3) results in a KCNQ1/KCNE1 complex that behaves as if it were the 
KCNQ1/KNCE3 complex. I hypothesize that this is due to changes in flexibility in the 
transmembrane helix of E1 when the TVG triple mutation is introduced in place of the 
native FTL sequence. To investigate this hypothesis, I used NMR techniques to assign 
E1FTL⇢TVG and determine structural differences between E1FTL⇢TVG, E1 and E3. 
 
 
3.1.1 NMR Assignments: Background 
 
A central benefit of NMR protein investigation is the possibility of monitoring proteins at 
residue-specific resolution over multiple time-scales.  While the 2D TROSY experiment 
gives some information, such as insight into whether the protein is properly folded, 3D 
NMR TROSY and other isotopically label experiments provide a route to site-specific 
resonance assignments that enable characterization of specific residues within the 
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protein. This includes determining (“assigning”) which residue in the protein gives rise to 
each TROSY contour peak, making each peak a reporter of residue-specific 
information. 3D TROSY experiments allow for a “sequential walk” through the protein 
backbone that provide the basis for residue assignment of both the amide 1H/15N 
peaks and also the backbone 13C(alpha), 13C(carbonyl), and 13C(beta) peaks. Using a 
combination of experiments, I can identify and assign each residue in the sequence.  
 
Many of the 2D and 3D TROSY experiments used to make assignments require the 
protein to be isotopically enriched. There are two types of isotopic labeling, uniform and 
selective.  Non-selective labeling involves the enrichment of all amino acids with 13C, 
15N, and/or 2H.  Selective labeling involves isotopic labeling of only a single reside 
type. There are also “inverse labeling” techniques that allow for the labeling of all other 
residues except one type of amino acid. Because 1H is the only NMR isotope that is 
found naturally in high abundance in proteins, others (2H, 13C, and 15N) must be 
enriched artificially [61, 62]. Isotopic labeling can be accomplished by providing cells 
with the selected isotope so that it substitutes natural isotopes and incorporates the 
otherwise rare isotope into the protein [61]. Isotopic labeling is an essential tool for 
biomolecular NMR for all but the simplest of proteins. Once a protein is labeled, this 
paves the way for experiments that enable resonance assignments and to spectral 
parameters that convey structural information. 
 
In this chapter I describe the expression and purification of isotopically-labeled 
E1FTL⇢TVG in mg quantities in order to make protein NMR assignments and to study its 
structural elements. I describe the results of our efforts to clone the cDNA for E1FTL⇢TVG 
into a suitable E. coli expression vector. The ability to purify membrane proteins like 
E1FTL⇢TVG requires the protein to be solubilized into complexes containing lipids or 
detergents, which allows them to be studied in solution [63]. This purification in to 
detergent micelles is described in this chapter. Last, isotropically labeling will allow for 
NMR studies and the assigning of E1FTL⇢TVG using a series of 2D and 3D NMR based 
experiments. These E1FTL⇢TVG studies will be compared to those of the previously 
studied E1  [41] and E3  [53] in the hope of elucidating the structural and dynamic 
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differences of wild type E1 and the E3-like E1FTL⇢TVG mutant. The data results of this 
chapter based on the published data of Law 2019 [64]. 
 
 
3.2 Results 
 
3.2.1 Cloning of E1FTL⇢TVG 
 
The cDNA for E1FTL⇢TVG was created from a WT E1 cDNA template using site-directed 
mutagenesis to replace the F57, T58, and L59 WT residues with T, V, and G, 
respectively (corresponding to wild type E3 residues 71-73). Also, because previous 
members of our lab determined that the C106 residue near the C-terminus causes the 
formation of disulfide-linked dimers under our purification conditions, this lone cysteine 
residue was mutated using quick change mutagenesis to generate C106S. The 
E1FTL⇢TVG template was cloned into the ampicillin-selective pET16b expression vector, 
which contains a readily-inducible T7 promoter that facilitates the expression of 
recombinant proteins [65, 66].  This vector also contains 3 cloning sites and an in-frame 
sequence that encodes an N-terminal His6-tag to facilitate purification (Figure 8) [56, 
67].  
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Figure 8: Schematic of the pET16b Cloning Vector 
The cDNA for E1FTL⇢TVG   was cloned into an 1177 base pair pET16b vector. The yellow line indicates 
where the cDNA was cloned into the expression vector in-frame with the His6-tag sequence in the small 
pink arrow. This figure was created from GenHunter when E1FTL⇢TVG cloning was confirmed. 
 
 
 
The E1FTL⇢TVG containing plasmid was transformed into a competent E. coli XL-1 Blue 
strain for expression because this strain lacks endA and recA, which improves miniprep 
results and increases insert stability. Transformation onto agar plates containing 
ampicillin for selectivity resulted in several single colonies after a 16-18 hour incubation 
period at 37°C. Five single colonies were selected for inoculation in LB media and then 
later mini-prepped to isolate the E1FTL⇢TVG DNA. The mini-prepped sample was 
submitted to the company GenHunter for sequencing to confirm that the DNA 
sequences encoded the TVG mutation, as well as the C106S mutation. Sequencing 
data determined that both mutations had been appropriately incorporated (Figure 9).  
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Figure 9: Sequence Results Confirming All Mutations and Sequencing Were Correct 
DNA sequencing confirmed the correct cloning of the  E1FTL⇢TVG sequence, which encodes the amino 
acid sequence as shown. This sequence included a His6-tag and a correctly inserted TVG mutation. The 
lone cysteine (site 106) residue was deleted, and a serine residue was added in its place. The mutations 
introduced are highlighted in red boxes.  The WT length is 129 residues and, with the His6-tag and flexible 
Gly linker, our total construct contains 136 residues. This image is from GenHunter to confirm site 
directed mutations were correct when cloning. 
  
 
 
3.2.2 Overexpression of the E1FTL⇢TVG Protein 
 
To determine the best E. coli strain for expression, protein expression tests were carried 
out in the following strains of competent cells: XL10-Gold, Rosetta C43(DE3) [49], and 
BL21(DE3) CodonPlus RP [56]. I tested XL10-Gold cells because of its high 
transformation efficiency while Rosetta C43(DE3) is generally good at expressing toxic 
proteins like membrane proteins. The BL21(DE3) CodonPlus RP cell line was selected 
because it contains extra copies of genes that encode tRNAs that recognize rare 
arginine and proline codons and has occasionally has high expression levels for 
membrane proteins. Of the 3 strains, the transformation of BL21(DE3) CodonPlus RP 
yielded several healthy single colonies and the highest expression levels of His6- 
E1FTL⇢TVG. Accordingly, for all following experiments, BL21(DE3) CodonPlus RP was 
used unless stated. LB media and 15NH4Cl M9 media were used to grow and induce 
15N-His6-E1FTL⇢TVG expression and yielded approximately 2.5g of cells per liter of 
culture.  Cells from a liter of culture usually yielded 2.5-4mg/mL of pure E1FTL⇢TVG . 
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3.2.3 Purification of KCNE1FTL⇢TVG into Detergent Micelles 
  
I first started by repeating the purification of WT E1 [56] and subsequent NMR.  In my 
hands, this yielded poor spectral quality, suggestive of an unfolded E1 protein. Through 
adjusting several purification conditions, including replacing SDS with LS (at 
concentrations above the CMC), the new purification process yielded high-quality 
spectra for WT KCNE1. Using this new protocol, I then repeated the purification of 
E1FTL⇢TVG and collected 2D TROSY NMR spectra. An SDS-PAGE gel of purified  
E1FTL⇢TVG protein showed that it formed both monomer and dimer, possibly due to 
disulfide bond formation involving the single cysteine residue located in the C-terminal 
tail (Figure 10).  For this reason, I mutated C106S and observed that this eliminated 
dimer formation (Figure 11). Our construct for all subsequent studies contained the 
C106S mutation.  
 
 
  
Figure 10: Purification Gel of WT E1 With Native C106 
Purification gel for E1FTL⇢TVG with native C106 shows two bands around 15kDa and 30kDa. 15kDa and 
30kDa are the expected molecular weights for monomer and dimer, respectively. There appears to be an 
equal amount of dimer as there is monomer in this sample. Unpublished data performed by postdoctoral 
researcher, Congbao Kang. 
 
 
Like many toxic and membrane proteins that often do not incorporate well into the E. 
coli plasma membrane, His6-15N- E1FTL⇢TVG  was found to be expressed in inclusion 
bodies [56, 68] and solubilized as mentioned in chapter 2 before purification into 
membrane mimetic.  
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Attempts were also made to purify E1FTL⇢TVG into lipodisq nanoparticles (LDNP) using 
the amphipathic polymer (poly(styrene-co-maleic acid); SMA) to solubilize  DMPC and 
DMPG lipids [69, 71]. With this method, I hoped to purify E1FTL⇢TVG into a more native-
like environment, lipodisqs.  E1FTL⇢TVG was eluted into LDNP, but the polymer solution 
was viscous, even after dilution. When examined using NMR, no peaks were detected 
due to slow tumbling in solution.  
 
To summarize, attempts to purify E1FTL⇢TVG in LDNP lipodisqs failed. Because micelles 
are relatively small and well suited for NMR [72] LMPG detergent micelles will be used 
in all further studies. This detergent was previously identified [56] as being optimal for 
wild type E1.  LMPG is a lipid-like anionic detergent that is generally regarded as being 
relatively mild and non-denaturing. 
 
For purification of E1FTL⇢TVG into LMPG micelles, I added 10 mM and 30 mM imidazole 
column rinse steps to exchange buffer from LS into LMPG detergent micelles and to 
remove loosely bound impurities on resin. Imidazole competes with the His-tag bound 
protein-ligand sites on the nickel resin [73, 83]. An elution buffer containing 300 mM of 
analytical grade imidazole was used to elute the His-tagged protein from the resin. All 
fractions were collected and then subjected to electrophoresis on a 10% Tris-SDS 
PAGE gel to determine the purity of the sample. This optimized protocol and the C106S 
mutation appeared to eliminate dimerization in micelles (Figure 11).  
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Figure 11: Purification of E1FTL⇢TVG in LMPG Micelles  
The figure illustrates the purification of the protein via an SDS PAGE gel to show the purity of collected 
fractions. Lane 1: supernatant Lane 2: Flow-through from gravity packing Lane 3: LS wash to remove 
urea with 0.2% LS  Lane 4: 10 mM Imidazole wash with 0.2% LMPG Lane 5: 30 mM imidazole wash in 
0.2% LMPG  Lane 6: 300 mM imidazole wash 0.2% LMPG  Lane 7: Ni(II)-NTA resin Lane M: Simply Blue 
stain marker. Lane 6 shows reasonably pure E1FTL⇢TVG  and no dimer or oligomer formation. 
 
 
 
3.2.4 NMR Sample Preparation and Spectroscopy of E1FTL⇢TVG 
 
Most of my studies to gain structural information rely heavily on nuclear magnetic 
resonance (NMR) methods to probe the properties E1FTL⇢TVG at the atomic level. 1D 
spectra are usually not useful in this regard because of excessive signal overlap, 
obscuring useful information. Multidimensional NMR was used to disperse resonances 
in multiple dimensions, allowing access to a wealth of information. For many 
multidimensional NMR experiments, the protein must be enriched with NMR-active 15N 
and/or 13C isotopes [74]. 2D heteronuclear single quantum correlation (HSQC) or 
transverse relaxation-optimized spectroscopy (TROSY) [75, 76] pulse sequences was 
used to correlate backbone amide nitrogen-15 resonances to the resonances from the 
attached amide protons. After transforming the data and plotting as a 15N x 1H plot, 
each;/ contour peak represents a single amino acid. Each peak will have a unique 
combination of 15N and 1H chemical shifts, which are sensitive to the local environment 
of the amide group. E1FTL⇢TVG solubilized in LMPG detergent micelles forms a large 
complex. When the molecule or complex under study is relatively large, 2D TROSY is 
preferable to 2D HSQC because it yields shaper peaks, leading to enhanced resolution 
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and, in some cases, signal-to-noise. Shown in Figure 12 is the TROSY NMR spectrum 
of E1FTL⇢TVG in LMPG micelles, a spectrum that displays well dispersed and sharp 
peaks (Figure 12).   
 
 
 
 
Figure 12: 2D 1H,15N-TROSY Spectrum of E1FTL⇢TVG 
2D TROSY NMR spectra of 15N-E1FTL⇢TVG in LMPG micelles. 116 of the expected 122 peaks can be 
identified, and the spectral resolution is high.  Both tryptophan indole side chain NH resonances can be 
seen in the lower right inset. Of the 122 expected peaks, 116 peaks can be identify. The inset in the top 
left corner shows the purification gel illustrating sample purity and monomeric E1FTL⇢TVG. This figure is 
from reference 64.    
 
 
 
3.2.5 Uniform Isotopic Labeling and Sample Preparation 
 
Uniform isotopic labeled proteins using 2H,13C, 15N isotopes allow for elucidation of 
backbone resonance assignments via 3D NMR experiments. I first tried uniform, triple-
isotope labeling to generate U-2H, 15N, 13C-E1FTL⇢TVG. Cells were grown in media 
containing increasing percentages of D2O up 100% and also supplemented the media 
with 15NH4Cl and 13C6-glucose. The same protocol used for purifying 1H,15N-E1FTL⇢TVG 
was used. Ideally, I would hope to see the same quality spectra as observed for the 15N-
labeled-only  1H,15N-E1FTL⇢TVG samples. Unfortunately, cells in 100% D2O-based media 
exhibited limited growth and prevented growth to a sufficient optical density before cells 
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began to show evidence of death. Cells grew well in 70% D2O and so were therefore 
grown in 2L of media in 70% D2O-containing M9 media in hopes that this condition 
would result in sufficient quantities for an NMR sample. This yielded a sample that was 
purified to approximately 0.1 mM and yielded a 2D TROSY spectrum following 12 hours 
of spectra acquisition. However, the quality of the spectrum from U- 2H, 15N, 13C-
E1FTL⇢TVG in 70% D2O (Figure 13) indicates that under our conditions, the triple labeled 
E1FTL⇢TVG sample showed several missing peaks and poor resolution, concluding that it 
was not properly folded under these conditions and was therefore not amenable for 
further NMR studies.  
 
 
 
 
Figure 13: Triple Labeled Sample of E1FTL⇢TVG 
TROSY spectrum of 2H, 15N, 13C-E1FTL⇢TVG in 70% D2O run on a 900MHz spectrometer for 12 hours at 
318.2K. The final sample contained 30 mM imidazole, 8% LMPG, 0.1 mM protein at a pH of 6.5. Several 
peaks are missing and not well resolved. This spectrum is indicative of a protein that is not well folded 
and not amenable for assignment experiments. 
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Since triple labeling E1FTL⇢TVG was not successful at providing a sufficient quantity of 
protein or spectra of the high quality spectra required for assignments, a uniformly 
isotopically double labeled sample, U-13C,15N-E1FTL⇢TVG, was generated by substituting 
D2O with standard H2O in the medium. This sample was created using the protocol of 
growing cells in 15N-M9 media with the alteration of 2 grams of 12C6-glucose for 2 grams 
13C6-glucose. Sample growth was normal. Purification and NMR TROSY spectroscopy 
followed the standard protocol, yet yielded spectra that were poorly resolved and 
missing several peaks suggestive of a poorly folded protein. I attempted to increase the 
temperature from 318.2K to 323.2K in hopes of obtaining a better resolution but to no 
avail. However, it was found that increasing the amount of 13C6-glucose used per liter 
from 2g to 4g per liter of culture increased the yield dramatically, allowing preparation of 
a 1 mM protein sample in 8% LMPG. This TROSY spectrum demonstrated that 4g 
yielded a well-dispersed spectrum (Figure 14). 
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Figure 14: Overlay of the Double-labeled Samples with 2 Versus 4 Grams of 13C6-glucose  
Overlay of 13C,15N, E1FTL⇢TVG spectra with 2g (red) and 4g (black) of 13C6-glucose. 13C,15N- E1FTL⇢TVG 
grown in 4g glucose produced well-dispersed spectra. 13C,15N, E1FTL⇢TVG grown in 2g glucose is missing 
several peaks, does not align well with the 4-gram sample, and not resolved well enough to make 
assignments. 
 
 
The 1H,15N-TROSY spectrum from a 13C,15N, E1FTL⇢TVG sample prepared with 4g of 
glucose per liter of culture was compared to that of the 15N-E1FTL⇢TVG prepared with 
12C6-glucose to determine if peaks overlay. The two samples were prepared and 
purified side by side and the two spectra aligned well, with only a few minor shifts 
(Figure 15). This was a strong indicator that the sample could be used for 3D 
experiments to make assignments.  
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Figure 15: Overlay of 15N-E1FTL⇢TVG and 13C,15N-E1FTL⇢TVG containing 4 grams of 13C6-glucose 
The red peaks represent 15N-E1FTL⇢TVG. The blue peaks show 13C,15N-E1FTL⇢TVG. Both samples were 
prepared and purified side by side under the same conditions and processed using the same parameter. 
Both samples contained 1 mM E1FTL⇢TVG , 8% LMPG, 30 mM imidazole and 10% D20 at pH 6.5. There 
are a few subtle shifts but there are no peaks missing or significantly shifted seen in the spectrum from 
the double-labeled sample. 
 
 
Our lab has previously studied WT KCNE1 and has published its assignments and 
structure [56]. Since E1FTL⇢TVG was created by QuikChange Mutagenesis from WT 
KCNE1 and thus has a very similar sequence, I wanted to determine if the mutations 
induced a significant change in chemical shifts from that of WT E1. This would mean 
that the addition of mutations did not significantly disrupt the structure or fold of the 
protein. The overlay of the 13C,15N-E1FTL⇢TVG  and the WT 15N-E1  spectra (Figure 16) 
indicates that 13C,15N-E1FTL⇢TVG has very similar chemical shifts to that of the published 
and assigned WT 15N-E1.  
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Figure 16: Overlay of WT KCNE1 and E1FTL⇢TVG. 
Red peaks are from WT 15N-E1. Blue peaks are from 13C, 15N- E1FTL⇢TVG. A few peaks are missing due to 
them being removed by mutations or by peak broadening. Other peaks can be seen in blue that have no 
red counterpart. This may be due to the mutations introduced or peaks being better resolved in the 
mutant sample. Overall the two spectra indicate that the folds of the two proteins are very similar. 
 
 
While there are a few peaks that have shifted, disappeared, or are now present, the 
overall appearance of the spectra are similar. This was useful when making 
assignments for E1FTL⇢TVG due to our ability to transfer many resonance assignments 
from the published WT E1 study [56]. Even prior to starting any 3D TROSY 
experiments, approximately 65% of assignments could be transferred. It was also 
observed that 13C,15N-E1FTL⇢TVG contained some additional peaks that were not present 
in the published spectrum of WT E1. A number of peaks not seen for WT E1 are now 
present in the E1FTL⇢TVG spectrum. Of the 4 substituted peaks (F57T, T58V, L59G, 
C106), 2 of them can easily be observed. Due to the unique chemical shift ranges for 
the Thr and Gly peaks, T57 and G59 were easily identifiable. Additional peaks not in the 
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original assigned and published spectrum were observed in new E1FTL⇢TVG spectrum. 
For the E1FTL⇢TVG spectrum, roughly 10 resonances that could not be assigned or 
observed in the original WT E1 spectrum were now observable. To confirm the identity 
of transferred peaks and to continue to make additional assignments for the mutant 
form, additional 3D TROSY experiments were used. 
 
 
3.2.6 3D TROSY Backbone Experiments for Making Resonance Assignments 
 
Making backbone assignments is the process of identifying and assigning the nuclei of 
an amino acid in a protein peptide that is observed in the NMR spectra. The peaks in 
the 1H-15N spectra map to each HN of each amino acid in the E1FTL⇢TVG sequence. In 
order to complete and confirm our assignments and to sequentially walk along the 
protein backbone, a series of 3D backbone experiments on uniformly 13C,15N-labeled 
E1FTL⇢TVG in a high field magnet were utilized. The experiments used were TROSY 
versions of HNCACB, HNCO, HNCA, HN(CA)CO, and HNCB. 
 
A simple way to visualize how a 3D TROSY experiment works can be seen below 
(Figure 17). I start with taking a 2D 1H, 15N TROSY spectra. All peaks in the 3D spectra 
can be mapped back to an individual peak in the 2D spectra, allowing for assignments 
to be made. The 3D experiments take the peaks from the 2D spectra and add a third 
dimension represented by the 13C plane and z-slices into the 15N  plane can be made. 
While moving through the z-planes and also move through the 15N axis of the 2D 
spectra will provide us with important information that facilitates the sequential walking 
of the backbone. 
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Figure 17: Schematic of 3D Experiments 
This schematic depicts an overview of the basics of a 3D NMR spectrum. (a) 2D plane showing proton 
and nitrogen dimension. Each peak corresponds to a backbone amide 1H-15N pair in the sequence. (b) 
The 2D plane is expanded in a third (i.e., carbon) dimension. (c) A model of peaks in a 3-dimensional 
space. (d) The pink shade represents a z-slice through the nitrogen plane.  (e) The z-slice moving 
through the nitrogen place, each showing different peaks that correlate back to the 2D plane seen in 
(a).This figure is from Victoria A. Higman, modified October 2012 on website https://www.protein-
nmr.org.uk/solution-nmr/assignment-theory/visualising-3d-spectra/ 
 
 
I first tested 1D, 2D TROSY and a 3D projection of the HNCACB experiment to show 
that the protein would produce high-quality 3D spectra before moving forward. These 
experiments indicated that the protein was present in sufficient quantities and that 
E1FTL⇢TVG peaks in the 2D TROSY and 3D TROSY projection were well resolved, 
leading to the continuation of further 3D TROSY experiments. The simplest and most 
sensitive of the 3D TROSY experiments used for sequential backbone walking is HNCA 
(Figure 18). In this experiment, the proton of residue I, H(i), is excited. This 
magnetization is transferred to the connecting nitrogen (N(i)), then to the Cɑ connected 
to H(i) (Cɑ(i)) and the Cɑ carbon of the previous residue Cɑ(i-1) [77]. The transfer of 
magnetization allows for correlation of peaks from one residue to those from the 
previous residue, enabling a sequential walk of the protein backbone (Figure 18, inset). 
When looking at a single nitrogen slice of the HCNA spectra, two aligned peak were 
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observed in the proton dimension in a single column. These peaks can be directly 
mapped back to the 2D 1H x 15N TROSY spectra. The more intense peak represents the 
Cɑ(i) and the less intense peak reveals the Cɑ(i-1) [78]. The peaks not aligned with any 
another peak in its column are likely Cɑ(i) from different nitrogen slices. Moving through 
nitrogen slices allows observation of the matching Cɑ(i-1) peak. In this figure, 4 sets of 
Cɑ(i) and Cɑ(i-1) within this one z-slice can be observed. Our data indicate the HNCA 
spectra is well resolved and allows us to see many Cɑ(i) and connecting Cɑ(i-1). The 
majority of Cɑ assignments were able to be made through this HNCA data, which aided 
interpretation of our other 3D data. 
 
 
Figure 18: Triple Resonance Experiment HNCA 
The figure displays an HNCA 15N slice. 4 sets of different Cɑ(i) and Cɑ(i-1) pairings can be seen. The 
larger, more intense peaks are the Cɑ(i) because the transfer of magnetization is much closer than the 
smaller Cɑ(i-1) where the magnetization pass through CO of the i-1 residue. The inset shows the 
excitation of H(i) and the transfer to the N(i), Cɑ(i), and the Cɑ(i-1). Inset adapted  from Horst Joachim 
Schirra November 1996 on http://www.cryst.bbk.ac.uk/PPS2/projects/schirra/html/trex.htm. 
 
 
Another important experiment is HNCACB. Similar to HNCA, it provides chemical shifts 
for Cɑ(i) and Cɑ(i-1), and also for Cβ(i) and Cβ(i-1). This allows us to sequentially walk 
the backbone and make Cβ assignments as well as Cɑ assignments. In this experiment, 
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H(i) is excited and the magnetization is transferred to N(i). The magnetization is 
transferred to Cɑ(i), Cβ(i), Cɑ(i-1), and Cβ(i-1) (Figure 19, Figure 19 inset). This allows 
us to detect Cβ(i) and  Cβ(i-1), which enables us to sequentially walk the backbone. In 
some columns, not all 4 peaks are present. As a result of moving through the z-slices, a 
set of 4 peaks lined up along the 13 C axis can be observed. Cɑ(i) and Cβ(i) are seen in 
the more intense red and green peaks while Cɑ(i-1) and Cβ(i-1) are the less intense red 
and green peaks. Some columns exhibit less than 4 peaks and some can show more 
than 4 peaks. This happens because the z-slice is not on the centers of the peaks and 
needs to be moved in either direction to find the peak center.  Alternatively, some of the 
peaks broadened so much that they are not observable and assignments cannot be 
made with that peak. When analyzing our HNCACB data, it was more common to have 
Cβ peaks broadened, possibly because of the number of atoms separating Cβ from the 
amide proton sites of excitation. 
 
 
Figure 19: Triple Resonance Experiment HNCACB 
The figure displays an HNCACB spectra 15N z-slice. The green peaks show Cɑ peaks where Cɑ(i) are 
more intense than Cɑ(i-1). The red peaks show Cβ peaks where Cβ(i) and more intense than the Cβ(i-1). 
The inset is a schematic of the transfer of magnetization pattern. Inset adapted from Horst Joachim 
Schirra November 1996 on http://www.cryst.bbk.ac.uk/PPS2/projects/schirra/html/trex.htm. 
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HNCO is the most sensitive of the 3D experiments (Figure 20), but it does not provide 
direct information for backbone walking. In this experiment, the magnetization is 
transferred to the CO(i-1). In figure 20, each peak represents the CO(i-1) associated 
with the nitrogen and proton of the i residue. Therefore, in any z-slice of the HNCO 
spectra, one would expect to see a single peak in a column while scanning through the 
z-slices. Two or more peaks in a 1H column would indicate that two or more peak have 
the same nitrogen and proton chemical shifts within the 2D TROSY spectrum. The 
HNCO spectrum can become useful in resolving overlapping peaks in 2D TROSY 
spectra.  For example, in the left panel of figure 21 a very intense peak labeled K70 is 
identified in the 1H,15N 2D TROSY spectra. When looking at the corresponding peak in 
the HNCO spectra, 2 peaks can easily identify, indicating that the intense K70 peak 
seen in the 1H,15N 2D TROSY spectra is actually 2 overlapping peaks. This aided in 
deconvoluting several overlapping peaks in the 2D TROSY spectra and in other 3D 
spectra. 
 
 
Figure 20: 3D Experiment HNCO 
This figure depicts the HNCO spectra of E1FTL⇢TVG. The inset figure shows the CO(i-1) by transferring 
magnetization from the H(i) and N(i) to the CO(i-1). Each peak corresponds to a CO(i-1) that can be 
mapped back to the 2D TROSY. Inset adapted from Horst Joachim Schirra November 1996 on 
http://www.cryst.bbk.ac.uk/PPS2/projects/schirra/html/trex.htm. 
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Figure 21: K70 Overlapping Peaks Identified in HCNO 
The left panel shows a zoomed-in region of the 2D TROSY spectra. In this figure, I observe that K70 (left 
panel boxed in blue) is very intense. This peak can be mapped to peaks in the HNCO spectra in the blue 
highlighted section in the right panel. The right panel shows 2 peaks aligned in the HNCO spectrum, 
which correspond to two overlapped peaks in the TROSY spectrum. This figure is from reference 64. 
 
 
3D-TROSY based experiments were used to confirm the assignments that were 
transferred, make assignments that could not be transferred, and to provide chemical 
shift data for CO, Calpha, Cbeta, Halpha, HN, and N. All spectra were collected using a 
900MHz spectrometer under the same conditions mentioned in the Methods section. 
The data was processed in TopSpin and analyzed in NMRfam-SPARKY. Peaks were 
picked automatically than manually checked and edited by hand. 
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Figure 22: Sequential Backbone Walking of Five Residues in an HNCA Spectrum 
In this figure, an example of sequential backbone walking from residues T14 to Q18 is shown. The red 
line indicates the Cɑ(i) connecting to the matching Cɑ(i-1), then to the next residue, Cɑ(i+1). Continuing in 
this manner, connections can be made to assign residues sequentially. This figure is from reference 64. 
 
 
Combining all of these methods, I was able to connect, assign, and verify approximately 
65% of the residues. It was useful to start with amino acids that have unique chemical 
shifts that are easy to identify, such as glycine, which does not have a Cβ, or alanine, 
that has Cɑ chemical shifts that exhibit much lower values than other amino acids. 
These 3D experiments provided data to correctly assign several misassigned peaks 
transferred from WT E1 and to confirm and make new assignments.  
 
While these experiments provided a wealth of information to make assignments and 
sequentially walk through segments of the protein backbone, several assignments could 
not be completed using this data alone, particularly in the transmembrane regions 
(Figure 22). Other experiments, such as single and inverse amino acid labeling provided 
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excellent tools to fill in missing assignments. In the next section, I detail single and 
inverse labeling and the completion of assignments. 
 
 
3.3 Single and Inverse Amino Acid Labeling 
 
 
3.3.1 Single Amino Acid Labeling 
 
Specific amino acid labeling allows us to isotopically label all residues of one specific 
amino acid type in the entire sequence. Therefore, the spectrum will display peaks from 
only the amino acid type that was isotopically labeled. To begin single amino acid 
labeling, I selected 6 amino acids for which additional data were needed to complete 
missing assignments. Using CT19 cells in minimal medium, the 15N-amino acid of 
choice were spiked into the media towards the end of the standard growth protocol, just 
before IPTG induction. Both use of CT19 cells and the addition of 15N-labeled amino 
acids just before induction helps to reduce scrambling during the synthesis process. 
These samples were harvested and the E1FTL⇢TVG  was purified to yield between 2.3-5 
mg of pure protein per liter for each amino acid labeled (Figure 23). The amino acids 
that were labeled were Leu, Ala, Phe, Met, Ile, and Val. These amino acids were 
chosen because they were overrepresented among the remaining unassigned residues, 
the location of the residues on the sequence, and the relatively low price of the labeled 
amino acid in each case. 5 of 6 of the single amino acid labeled samples exhibited very 
little impurities, showed all or the majority of the peaks, and overlaid well with peaks 
seen in the TROSY spectrum of E1FTL⇢TVGTROSY (Figure 23, Figure 24, Supplemental 
Figures 1-5).  
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Figure 23: SDS PAGE Gel of E1FTL⇢TVG Samples Labeled with One of 5 Specific Amino Acids  
Displayed above is a gel documenting the final purification state of E1FTL⇢TVG labeled with either  
15N-Met (lane 1), 15N-Leu (lane 2), 15N-Ala (lane 3), 15N-Val (lane 4) and 15N-Ile (lane 5) and two different 
concentrations. The last lane is a marker to show approximate molecular weight. 
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Fig 24: Single Amino Acid Label Sample for Val 
This figure shows single 15N-amino acid labeling of Ala residues in red (top) and of Val residues in red 
(bottom). The blue (top) and black (bottom) peaks are from the 2D TROSY of  E1FTL⇢TVG . This figure 
shows all 10 of the expected peaks for Val highlighted in red and align with the 2D TROSY spectra (in 
black) and the assigned Val residues.  
 
 
The 15N-Met spectrum shows 4 peaks from a total of 4 residues. The Ala spectrum 
shows 6 out of the 7 expected peaks while the Leu spectrum show all 13 expected 
peaks. The Phe and Val spectra display 5 and 10 expected peaks, respectively, as 
expected. Specific labeling of selected amino acids provided a significant number of 
additional assignments.  
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3.3.2 Inverse Isotopic Labeling of Specific Amino Acids 
 
I also utilized the technique of “inverse labeling” which enabled us to isotopically label 
all residues in our sequence, with the exception of one selected amino.  Peaks from that 
amino acid type are identified because they disappear from what is otherwise an 
ordinary TROSY spectrum.  
 
While Ser and Thr have unique chemical shifts around 116 ppm in the nitrogen 
dimension, inverse labeled Thr (Figure 25) samples were created to better differentiate 
between the two amino acids. All 7 Thr peaks disappeared, which aided in completing 
assignments and confirming the T57 mutation. Amino acids Ser was also inversely 
labeled, but the spectra showed that the labeling was not effective and few peaks were 
seen to disappear. 
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Figure 25: Inverse Labeling of Thr  
The black peaks show the E1FTL⇢TVG. The red peaks show all the residues in the sequence with the 
exception of Thr. The black peaks that do not have an overlapping red peak are Thr residues. All 7 of the 
expected Thr peaks disappeared. 
 
 
Using an iterative approach involving analyzing the 3D TROSY, as well as data from 
both specific labeled and inverse labeled samples, I were able to establish assignments 
for 86% of the peaks of the entire protein (Figure 26,Figure A) [64]. I also noticed that 
there are small number of residues (122, 125 and 126) that split into 2 individual peaks, 
perhaps arising from two slowly interconverting conformations. These peaks were also 
seen to be also be split in the published WT E1 spectra [56]. 
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Since I believe that the major structural difference between WT E1 and E1FTL⇢TVG lies 
within the transmembrane, I exerted special focus to complete 95% of the assignments 
within the transmembrane and juxtamembrane regions (9 residues on each side of the 
TMR), including peaks for all 3 of the TVG mutations that were introduced. With these 
assignments in hand, I proceeded to collect and analyze relaxation and topology 
experiments to determine flexible regions of the protein and which regions of the protein 
are inserted in the membrane. While most of these missing peaks were dispersed 
throughout the protein, there is one small region in the C-terminal (Figure 27). 
 
 
Figure 26: Resonances Assignments of E1FTL⇢TVG 
This figure shows all the assignments that could be made using the experiments described in this 
chapter. The left inset shows the final purification for the 13C, 15N-E1FTL⇢TVG sample. 
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Figure 27: Topology of Missing E1FTL→TVG Residues 
This figure depicts the topology of E1FTL→TVG. 7 prolines have been identified in yellow diamonds and the 
single Cys represented in blue. The TVG mutation can be seen in red within the tan transmembrane region. 
Peaks that could not be assigned are designated in gray. This figure was created using Protter - visualize 
proteoforms [79]. 
 
 
3.4 Chemical Shift-Based Secondary Structure Analysis 
 
TALOS-N is an online resource that allows determination of the protein backbone and 
side-chain torsion angles based on measured backbone chemical shift (CS) data [80]. 
From our assignment data, I was able to use the chemical shifts for C, Cɑ, Cβ, N, and 
HN for each residue to predict the secondary structure E1FTL⇢TVG (Figure 28, middle 
panel). Residues that have TALOS-N helical probabilities close to or equal to 1.0 
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indicate the residue is part of an alpha-helix. Helical probability values that are close to 
0 indicate random coil. The E1FTL⇢TVG TALOS-N plot predicts structured helical regions 
at both the N- and C-terminals around residues 9-22 and 87-104, and between residues 
41 through 73, which contain the inserted TVG mutation. These helical regions are 
connected by flexible disordered regions. One notable characteristic of the E1FTL⇢TVG 
TALOS-N plot is seen at residue 58, the site of the T58V mutation, where a slight drop 
in helicity within the middle of the helix is observed. Also noticed, at residue 49, is a 
decrease in helical probability of about the same percentage as at residue 58. 
 
To determine if the drop in helicity at residue T58V was due to the mutations introduced, 
I wanted to compare our E1FTL⇢TVG  data to that of WT E1 and WT E3. Assignments for 
both E1 and E3 have been published by our lab [81, 53] and CS information has been 
deposited into the BMRB database that houses published CS data for proteins. When 
running WT E1 and E3 CS data through TALOS-N, I were able to see helical predictions 
that were similar to  E1FTL⇢TVG but with some very notable differences (Figure 28, top 
and bottom panel). WT E1 CS data indicates helical structure spanning N-terminal 
residues 7-25, C-terminal residues 87-105, and the transmembrane region 42-71 that 
houses the functionally critical residues, FTL. Similar to  E1FTL⇢TVG, in WT E1 a 
noticeable drop in helicity can be seen at residue 49 and at and around the FTL region, 
specifically for residues 59, 60, 61, and 62. One interesting difference between WT E1 
and E1FTL⇢TVG  is that WT E1 shows a much more intense drop in helicity at 4 
transmembrane residues (site 59-62) while E1FTL⇢TVG  only shows a mild decrease and 
only at one residue. (Figure 28, middle panel). In both WT E1 and E1FTL⇢TVG,  residue 49 
shows similar helical reductions.  WT E3 CS data shows structured helical regions 
spanning residue N-terminal segments 9-26, C-terminal segments 90-97, and the TM 
segment 55-80, the latter of which contains the functionally important TVG motif. Unlike 
WT E1 and  E1FTL⇢TVG, where a decrease in helicity around important or mutated 
regions is noticed, TALOS-N predicted strong helical structure for E3 between residue 
55-80, including at and near the TVG motif (Figure 28, bottom panel). Interestingly, the 
percent of helical content of the mutated region of E1FTL⇢TVG  is intermediate between 
that of WT E1 and E3. The decrease in helical content with the TVG mutation 
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introduced into E1 makes the transmembrane region of E1FTL⇢TVG  more similar to E3 
[64]. This increase in transmembrane helical structure for E1FTL⇢TVG  relative to WT E1 
may help us understand how  E1FTL⇢TVG  function is changed. Additional experiments 
detailed in Chapter 4 were conducted to confirm the TALOS-N prediction and give us 
more information about the mutated TVG region. 
 
 
 
 
Figure 28: Chemical Shift Analysis Plot using TALOS-N 
This figure shows helical and random coil regions for WT E1, WT E3, and  E1FTL⇢TVG. Helical probabilities 
close to 1 indicated predicted helical structure while those close to 0 are predicted regions of random coil 
with no secondary structure. All 3 proteins were predicted to have 3 alpha helical segments that are 
connected by sections of random coil. This data has been obtained from reference 64. 
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Chapter 4 
 
 
Preliminary Data, Discussion and Future Directions 
 
 
4.1 Published Data and Discussion 
 
 
4.1.1 Purification  
 
The work of this dissertation represents the first step toward determining the E1FTL⇢TVG 
structure, its structural comparison to E1 and E3, and biochemical elucidation of how it 
interacts with the Q1 channel. Site-directed mutagenesis to mutate C106S and then 
F57T, T58V, and L59G was successful and paved the way to protein overexpression in 
E. coil in BL21 (DE3) CodonPlus RP competent cells. Healthy cell growth produced 
between 2.5 to 4 mg/ml of pure monomeric protein, a sufficient amount to perform high-
quality NMR experiments. The pET16 expression vector added an N-terminal His6-tag, 
allowing us to purify pure monomeric 15N-E1FTL⇢TVG into LMPG micelles using a nickel 
resin, enabling TROSY based NMR experiments. The dispersion of peaks seen in the 
TROSY spectra of E1FTL→TVG is typical for a reasonably well-behaved single-span 
membrane protein in detergent micelles and several of the previous assignments from 
wild type E1 could be transferred to E1FTL→TVG [56].  
 
 
4.1.2 Assignments 
 
3D-TROSY based experiments were used to confirm the assignments that were 
transferred, make assignments that could not be transferred, and to provide chemical 
shift data for CO, Calpha, Cbeta, Halpha, HN, and N. Inverse labeling and specific amino 
acids labeling were used to fill in missing assignments not obtained by transferring or 
sequential backbone walking using 3D data. Leu, Ala, Phe, Met, Ile, Val were all 
selected for single amino acid labeling and Thr was inversely labeled. These amino 
acids were selected because Thr and Val are residues of the FTL→TVG triplet 
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substitution and these amino acids were common among the unassigned residues after 
3D experiments. A total of 86 percent of the backbone resonances were assigned using 
these methods, with 95 percent assigned in the critical transmembrane and 
juxtamembrane regions. While I was not able to obtain 100% assignments, much of our 
studies were focused on the transmembrane region, specifically the FTL→TVG. 
Because of this, it was important to obtain a higher percent of assignments. This would 
allow us to gain more detailed information on how the FTL→TVG affected the 
transmembrane helical structure. 
 
While some of the peaks from E1FTL→TVG aligned well with those from the 1H,15N wild 
type E1, many others exhibited significant shifts in both resonances. The majority of 
these shifted peaks lie within the transmembrane regions, as might be expected given 
that this was the site of the triple substitution. Residues with the most highly shifted 
peaks (G52, F54, G55, F56, G60, L63) are each within 5 residues on either side of the 
TVG substitution, hinting that there might be structural changes from wild type E1 at and 
around the TVG mutation site. This suggests that these residues may undergo 
exceptional changes in the chemical environment around those residues. This could 
possibly be due to more or less flexibility or dynamics with the region due to the 
introduction of the TVG motif. Also of note, the TVG substitution added an additional Gly 
in a transmembrane region of WT E1 that is already Gly rich and also removed an 
aromatic Phe. Leu and Val are both nonpolar, branched amino acids and replacing one 
for the other might have little effect on function. However, Phe and Gly have different 
and unique structures. Phe has an aromatic ring, while Gly has only a single hydrogen 
for a side chain and typically allows backbone flexibility. While Gly is known as a helix 
breaker, it is quite commonly seen in transmembrane helices where it is believed to aid 
in helix-helix packing and facilitate tertiary and quaternary structure [82]. This additional 
Gly might play a role in stabilizing E1FTL→TVG packing and decreasing flexibility such that 
is it similar to that of KCNE3. 
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4.1.3 Secondary Structure of E1, E3, and E1FTL→TVG 
 
The 13CO, Calpha, Cbeta H, HN, and N chemical shift values were input into the TALOS-N 
web server for secondary structure analysis. TALOS-N data showed 3 alpha helical 
regions located at the N- and C-termini and in the transmembrane domain, all connected 
by unstructured loops or strands. Unsurprisingly, E1FTL→TVG has a similar secondary 
structure as E1 and E3. However, while similar, all three proteins displayed a few 
noticeable differences. Both E1FTL→TVG  and E1 exhibited a break in helicity in the TM 
region while E3 exhibits a continuous helix [53]. The TM segment of E1 exhibited a 
modest drop in helicity at and immediately after the wildtype FTL triplet that is critical for 
its unique function, located at residues 59-61 [41]. E1FTL→TVG showed a significantly 
smaller decrease in helicity and only at residue 59. This data supports the idea that TM 
segment in E1FTL→TVG is structurally more similar to E3 than it is wild type E1, possibly 
helping to explain why the triplet mutation converts E1FTL→TVG  into a functionally similar 
protein to E3.  
 
 
4.2 Addition Preliminary and Discussion 
 
4.2.1 T1 and T2 Relaxation 
 
To better understand if the break in helicity seen in E1 and E1FTL→TVG effects their 
flexibility, relaxation experiments were undertaken. Relaxation occurs when nuclear 
spins that have been excited in a magnetic field via application of a magnetic pulse 
return to their ground or equilibrium state. Dynamics and flexibility information can be 
extracted from these experiments due to the fact the transfer of energy from the excited 
nuclear state back to its ground state is mediated by molecular motions, both overall 
tumbling, and local flexibility. The T1 relaxation time is for relaxation of magnetization 
along long the axis of the static magnetic field (designated z) and is called the 
“longitudinal” relaxation time.  T2 is for relaxation of magnetization in the XY plane and 
is called the “transverse” relaxation time. Another relaxation experiment to measure 
dynamics and flexibility is the steady-state Nuclear Overhauser Effect (ss-NOE). ss-
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NOE experiments measure NOE-based changes in the 15N signal intensity after 
saturating the proton signal, measurements that are useful for detecting local backbone 
motions [63]. T1 and T2 experiments for membrane proteins are conducted by 
monitoring relaxation using a series of delay times through 2D TROSY- based NMR 
experiments [84]  
 
NMR relaxation experiments have been implemented on 15N-E1FTL→TVG samples. 
Preliminary 1D and 2D recordings of T1 and T2 measurements have been executed 
using 11 and 10 delay times (tau), respectively, and in the following order: 15ms, 
4000ms, 400ms, 30ms, 2000ms, 50ms, 1600ms, 100ms, 1200ms, 200ms, 800ms, for 
T1 and 3ms, 170ms, 8ms, 137ms, 17ms, 102ms, 34ms, 85ms, 51ms, and 68ms for T2. 
In our preliminary data,  spectra showed that at longer tau times, E1FTL⇢TVG  signals 
decayed for both T1 and T2 (Sup Figure 7). Signal decay corresponds to the spin state 
relaxing back to the ground state. 
 
 
 
Figure 29: T2 Relaxation Data for E1FTL→TVG. 
This figure shows the T2 relaxation data for E1FTL→TVG in ms. Data points at 0 indicate missing 
assignments or missing data. The amino acid residues are on the x-axis and the relaxation times in ms 
are on the y-axis. 
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Figure 30: T2 Relaxation Data for Wild Type KCNE1 
This figure depicts T2 relaxation data for WT KCNE1 in ms. The amino acid residues are on the x-axis 
and the relaxation times in ms are on the y-axis. Figure modified from reference 56 
 
 
 
 
 
Figure 31: T2 Relaxation Data for Wild Type KCNE3 
This figure shows the T2 relaxation data for KCNE3. The green blocks represent transmembrane regions. 
This data is from reference 53. 
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While figure 29 depicts only single-replicate data and the reliability of the data is not 
clear, T2 relaxation data show a general and similar pattern with wild type E1 (Figure 
30). Both have a relatively rigid N-terminal helix, residues 9 to 20, followed by a short 
flexible region before the less flexible TM domain, residues 41 to73. Wild type E1 data 
goes on to show a rigid C-terminal helix, residues 87 to 104, that is not seen in 
E1FTL⇢TVG.  The noisy C-terminal data for the mutant could be a result both of not having 
replicated the experiments or even poor sample/spectral quality. These issues can be 
rectified with doing further replicates on stable E1FTL→TVG. Interestingly, E1 shows 
roughly 3 residues in the TM domain that are less rigid than the other TM residues 
located near the critical mutation substitution. Within that same region, E1FTL⇢TVG only 
shows 1 residue (T57) that is slightly more flexible. These data appear to be consistent 
with the TALOS-N data, where E1 shows a larger area with a break in helicity, while 
E1FTL⇢TVG shows a much smaller area. KCNE3 (Figure 31) shows similar results as 
E1FTL⇢TVG in that E3 only show 1 residues with increased flexibility in the TM region at 
residue T71. In E1FTL⇢TVG and E3, residues T57 and T71 show similarities in flexibility 
within the transmembrane region. Interestingly, these two residues are both Thr and are 
part of the FTL⇢TVG switch. 
 
Again, this would suggest that E1FTL⇢TVG has a more rigid transmembrane helix similar 
to E3, and contributes to   E1FTL⇢TVG and E3’s functional similarities. The Thr residues 
may also play a key role in flexibility. Here I compare only T2 data because it is more 
informative than T1 and E1 WT only has T2 data published. Again, our E1FTL⇢TVG is in 
need of a much more rigorous study and future experiments completing ss-NOE 
experiments and plotting of 1/T1 (R1) and 1/T2 (R2) as they are much more reliable and 
will give better insight to flexible regions of E1FTL⇢TVG. In our future experiments, I hope 
that the T1 and T2 data will corroborate our preliminary data, and be more precise in 
residue flexibility and provide better resolution of the C-terminal helix. Re-analyzing the 
raw E1 relaxation data to compare T1 and T2 data to that of E1FTL→TVG would give more 
insight of the differences in flexibility of E1FTL⇢TVG and E1. 
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4.2.2 Amide Hydrogen Exchange Measurements 
 
To better understand what could be happening at the helical break and the possible 
flexible segment in the TM region, amide-water hydrogen exchange experiments might 
allow us to determine if these residues contain water-exposed amide sites not part of 
stable alpha helices. Experiments such as CLEANEX-PM can be a powerful tool for 
assessing structural information. While water exchange techniques are useful, many of 
them are plagued by artifacts that make interpreting data difficult or impossible. The 
Phase-Modulated CLEAN chemical EXchange (CLEANEX-PM) spin-locking sequence 
is unique because it eliminates artifacts that are often seen in traditional water-proton 
exchange experiments [63, 58]. The CLEANEX-PM spin-locking module is combined 
with an HSQC pulse sequence to create a 2D experiment useful for quantitating 
exchange rates. The CLEANEX-PM spin-locking module is applied after water is 
selectively excited and while amide protons and water are exchanging [58].  
 
To test water accessibility, I conducted a preliminary test using 15N-E1FTL⇢TVG and 15N-
E1 and ran a CLEANEX-PM module with delay times at 25ms and 100ms. To quantify 
this data, ratios of peak intensities for the 25 ms delay CLEANEX-PM spectrum against 
those from the reference sample for both WT E1 and E1FTL⇢TVG proteins were plotted 
(Figure 32, Figure 33). In WT E1 the transmembrane region, 47-74, I noticed that 
residues 56, 57, 58, 59, and 60 have a higher ratio suggesting the backbone amide 
protons are experiencing some exchange with water protons. Included in this region are 
mutated amino acids 57, 58, and 59.  WT E1 residues 56, 57, and 58 have mild proton 
exchange while 59 and 60 have more significant exchange  4-6 times higher than that of 
56 and 57 (Figure 32). In E1FTL⇢TVG the data show similar patterns to E1 with E1FTL⇢TVG  
water accessibility within the middle of a transmembrane helix. One notable difference 
is that E1FTL⇢TVG only shows water accessibility at residues 58 and 59 and their 
intensities are about half the amount of WT E1. While we do not have CLEAN-EX data 
for E3, hydrogen-deuterium exchange measurements show transient  contact with water 
at residues T71, S74, and Leu 75. The residue T71  is part of the functionally critical E3 
region and S74 and Leu 75 are in close proximity to that region [53]. Interestingly, 
E1FTL⇢TVG, E1, and E3 all experience contact with water within the transmembrane helix 
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and all are regions that are critical for their unique function. E3 NMR data-restrained 
molecular dynamics suggest that contact with water in the transmembrane helix at 
residues 71,74, and 75 stabilize E3 curved helix by decreasing the energetic cost of 
breaking backbone hydrogen bonds [53, 85].  Our lab has extensively shown that WT 
E1 helix is also curved [41, 86] and therefore I hypothesize that  E1FTL⇢TVG is also 
curved and this curved nature of the helix for all 3 proteins is stabilized due to their 
contacts with water in the TM region. While E1FTL⇢TVG and E3 show water accessibility 
to 2 and 3 residues, respectively, E1 has 5 residues exposed to water in the TM region. 
This would suggest that simply having water accessibility is not a factor when 
differentiating function, but the amount of amino acids that interact with water might lead 
to both structural and functional differences. 
Because CLEANEX-PM data has only been performed once and the data is very noisy, 
it is a bit premature to make a concrete conclusion that these sites in E1 have a higher 
water accessibility than E1FTL⇢TVG. Further, replicate experiments are required, but if 
confirmed, it would align with our TALOS-N and T2 relaxation data suggesting that E1 
has a larger stretch of TM residues with reduced helicity and possibly more flexible, 
which allows more water penetration and exchange with more TM  residues in wild type 
E1. E1FTL⇢TVG and E3 both experience water accessibility but to a lower decrease which 
could possibly lead to a stronger helical structure in that region. It will be exciting if 
further CLEANEX-PM experiments validate our preliminary data.  
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Figure 32:  CLEANEX-PM 25ms Data for WT E1 
This figure shows the CleanEX-PM (HSQC) of WT E1 with an exchange delay of 25ms. Residues with a 
high peak intensity ratio indicate high water-amide hydrogen exchange while low values indicate residues 
protected from exchange. Peaks located at -0.2 are for peaks that were missing or unassigned.  
 
 
 
 
Figure 33: CLEANEX-PM 25ms Data for E1FTL⇢TVG 
This figure shows the CLEANEX-PM (HSQC) of E1FTL⇢TVG with an exchange delay of 25ms.  Residues 
with a high peak intensity ratio indicate water accessibility while low values indicate residues protected 
from water exchange. Residues fixed at -0.2 indicate residues that could not be assigned or for which the 
peak is missing. 
 
 
4.2.3 Comparison of E1, E3, and E1FTL⇢TVG  
 
The highest degree of sequence identity between the 3 KCNE proteins occurs at the 
beginning and end of their TM  domain, and E1, and E3 exhibit a curved or kinked TM 
helix yet they bind and modulate KCNQ1 in different manors. The first thing to make 
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notice of is the TM sequence surrounding the critically functional regions (Figure 34). 
These regions are 5 amino acids before the 3 residue functional region and 4 residues 
after it. The FTL amino acids of E1 and the TVG amino acids of E3 and E1FTL⇢TVG all 
have nonpolar Thr amino acids and beta-branched amino acid Leu and Val, 
respectively. All Thr residues are exposed to water molecules and exhibit some level of 
flexibility in E1, E3, and E1FTL⇢TVG. One significant thing that differentiates the FTL or E1 
and the TVG of E3 and E1FTL⇢TVG is the large, bulky aromatic Phe of E1 and the flexible 
single hydrogen atom sidechain Gly in E3 and E1FTL⇢TVG. The removal of the large 
aromatic ring in the E1FTL⇢TVG could play a large factor leading to the structure, 
interactions, and function of  E1FTL⇢TVG. 
 
 
 
 
Figure 34: Experimentally Determined KCNE1 and KCNE3 and Topology of E1FTL⇢TVG 
This figure show experientially determine KCNE1 (left) and KCNE3 (right) and E1FTL⇢TVG  
Topology (center) transmembrane regions. Highlighted in red is the functionally critical motif surrounded 
by 4 or 5 amino acids of the sequence on either side of the motif. The highlighted residue on KCNE1 
indicates T57 while KCNE3 shows critical residues that sit on the concave face of the curve, T71, S74, 
G78. 
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In order to better understand the FTL⇢TVG mutation, it is helpful to understand the 
important interactions of WT E1 and WT E3. In WT E1, T58 (Figure 34, first panel) 
residues interacts directly with the S6 helix at residue F339 [87-89] to stabilize the 
closed state [47]. With the addition of the TVG mutation, the Thr residue is moved 
upwards by one residue. It is also likely that Q1 F339 plays a role in the gating of the 
channel. I hypothesize that this mutation eliminates the  Thr and S6 F339 of interaction  
of E1 that stabilizes the closed state and makes the channel easier to open at initial and 
lower voltage potentials. It is possible this the T57/F339 interaction disruption also 
eliminate gating of the channel leading to a constitutively active channel. We also know 
that the bulky F57 residue helps stabilize the pre-open intermediate state is now 
missing  from WT E1. These are 3 possible reason why the FTL⇢TVG mutation leads 
to an constitutively active E1 channel.  
 
 
4.3 Future Experiments 
 
 
4.3.1 Paramagnetic Probe Access Experiments 
 
When studying membrane proteins, it is often important to understand the membrane 
topology—how the protein sits and/or interacts in the membrane. To investigate 
membrane topology for a membrane protein in a model membrane environment, 
paramagnetic aqueous and lipophilic probes (Gd(III)-diethylenetriaminepentaacetic acid 
(Gd-DTPA) and 16 DOXYL-stearic acid (16-DSA), respectively) were used as 
relaxation-enhancement agents. Comparing the spectra of each paramagnetic probe to 
that for a reference sample in the absence of the probe allows us determine which 
residues lie within the membrane or are exposed to solution. These probes work by 
promoting the rapid NMR relaxation of nuclei that are in close proximity to the probe, 
resulting in line broadening. Those residues not close to the probe are unaffected. Gd-
DTPA, a compound often used as a contrast agent, is a water-soluble paramagnetic 
probe based on the paramagnetic Gd3+ ion [63, 90]. Its presence will cause the signal of 
water-exposed residues to broaden. 16 DOXYL-stearic acid (16-DSA), also a contrast 
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agent, is a hydrophobic paramagnetic probe that partitions into the membrane and 
broadens NMR-active nuclei located on lipid-exposed hydrophobic segments [63, 91].  
Sites buried deep in protein tertiary structure are protected from both probes. 
 
Our preliminary studies used the same sample conditions previously used for KCNE3 
[53] as a starting point for both 16-DSA at 0.7 mM and Gd-DTPA at 20 mM. Peak 
intensities for both 16-DSA and Gd-DTPA spectra were compared to the corresponding 
peaks in the reference sample absent of any paramagnetic agents. These probes work 
by relaxing NMR active nuclei that are within close proximity. While these experiments 
at the mentioned concentration did cause relaxation in a reasonable pattern, further 
experiments and possible varying concentrations are needed (preferably in triplicate) to 
better understand the topology. These data will be compared to the already published 
data for E3 [53]. Corresponding studies of E1 will also need to be performed to better 
understand if differences in the TM helix affect its position within the membrane phase. 
These data would provide information regarding whether E1, E1FTL⇢TVG and E3 have 
different residues, particularly in the ends of the transmembrane helix, that are sitting in 
the membrane or not.  
 
 
4.3.2 Structural Restraints 
 
To calculate a three dimensional E1FTL⇢TVG structure, it will be necessary to gather 
distance and orientational restraints. To gain distance restraints on the structure for 
membrane protein such as E1FTL⇢TVG, paramagnetic relaxation enhancement 
experiment (PRE) are often employed to gather short, medium, and long range 
distances. This experiment works by chemically attaching a single spin-label on 
E1FTL⇢TVG through selectively placed Cys residues. Based on the distance from the 
paramagnetic spin label, each NMR active nucleus will be affected differently, with sites 
close to the probe being strongly relaxed, leading to broadened resonance peaks.  
 
To make these measurements, mutating out all wild type Cys residues in the sequence, 
then introduce a single Cys residue in specifically selected locations must be done. 
  62 
Since our E1FTL⇢TVG construct has already removed all Cys residues to prevent 
dimerization, site-directed mutagenesis can easily be performed to incorporate 
additional cysteines. I have created 5 single-Cys constructs (A44C, Y46C, S64C, Y65C, 
Y74C) that were overexpressed and purified. These sites were selected because they 
lie in the juxtamembrane regions or only a few residues into the TM.  These sites should 
be easy to label, but are located on relatively rigid parts of the protein, which will means 
extracting distances from the associated PRE measurements easier. Preliminary 2D 
TROSY experiments were carried out.  While generally of low quality due to low 
concentration and use of a low field magnet, the spectra do appear to be similar to the 
spectrum for the parent E1FTL⇢TVG mutant.  Future samples will need to purified to high 
enough concentrations and run on a high field magnet to ensure high quality NMR 
spectra.  The resulting spectra should hopefully establish that the mutations have not 
affected the fold. If some spectra suggest a misfolded protein, further experiments 
would have to carried out to identify more suitable residues for mutation to cysteine and 
spin labeling, located within the same area of the protein. 
 
Once mutations are confirmed and are verified to not significantly alter the chemical 
shift profile, a thiol-reactive spin label probe, MTSL, would be attached to the single Cys 
residue and a pair of matched 1H,15N-TROSY spectra  would be acquired, one with the 
paramagnetic probe and then one in which the paramagnet has been quenched with 
ascorbic acid to convert the paramagnet to a diamagnet. The peak intensity ratios for 
the paramagnetic sample relative to those from the matched diamagnetic sample are 
used to assess distances between the paramagnetic probe and each amino acid 
residue [53, 92, 93]. Intensity ratios less than 0.15 are considered close in space (<12 
angstroms between the probe and amide proton). Residues that experience moderate 
effect from the paramagnetic probe are medium in proximity (quantifiable in the 12-20 
angstrom range), while those that exhibit little effect (less than 15% reduction in peak 
height due to broadening) are considered far (>20 angstroms) [94]. This anticipated 
data will provide distance restraints to aid in calculating our E1FTL⇢TVG structural 
ensemble. These experiments also will need to be done in triplicate as other 
experiments listed above to determine the most accurate structure calculation. 
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Other restraints used for calculating structure can be obtained from double electron-
electron resonances (DEER) data and residual dipolar coupling (RDC) experiments. 
DEER experiments relate to long range distances between 18-80 angstrom by attaching 
spin labels at 2 locations and measuring the distance between the two probes [86]. This 
requires introducing 2 strategically placed Cys residues, then attaching spin labels to 
these Cys residues, and measuring the distance between the two. Previous DEER 
experiments have been performed on E1 [86], and the previous results would be 
compared to our DEER data. While providing distance information, the length of the TM 
of both E1 and E1FTL⇢TVG can also determine. Combined with 16-DSA and Gd-DTPA 
data this will shed light on if the TVG mutation substitution affects how the E1FTL⇢TVG 
sits in the membrane. RDC’s provide structural restraints on the orientation of the bond 
vectors, typically the backbone amide HN, relative to the molecular frame. Using these 
restraints, the program Xplor-NIH can be employed [95] to begin calculating E1FTL⇢TVG 
structure. Observing the experimentally determined structures of E1, E3, and E1FTL⇢TVG 
will give us insight into how these protein are structurally different. Furthermore, 
computational docking of the E1FTL⇢TVG structure into the KCNQ1 structure can be 
employed to gain insight on how E1FTL⇢TVG modulates KCNQ1 differently from E1 and 
E3. 
 
In this study, I reported the backbone NMR assignments and secondary structure of the 
E1FTL→TVG mutant that exhibits E3-like channel modulatory behavior. The results of this 
work provide a first step in comparing results for this mutant with the known NMR-
determined structures of wild type E1 [56, 41] and wild type E3 [44, 53]. Our TALOS-N 
data show that the secondary structure of E1FTL→TVG at the mutation substitution site 
showed a slight decrease in helical structure relative to E3, but it was not as pronounced 
as that of E1. The completed backbone assignments for the E1FTL→TVG mutant also 
provide the basis for future studies of the 3D structure and dynamics of this membrane 
protein. I hypothesize that critical WT E1 contacts with Q1 that either gating or a pre-open 
state have been eliminated with the TVG substitution and leading to an Q1/E1 channel 
that behaves like an Q1/E3 channel.  There is already much published information about 
the E1 and E3 structures and a number of studies have proposed models for how these 
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proteins bind Q1 and differentially modulate the function of this important channel. I hope 
this study will help contribute to the understanding of KCNQ1 and its ancillary KCNE 
family proteins. More specifically, I hope this work will allow others to better understand 
how critical amino acids and their interactions with the KCNQ1 channel can be 
manipulated to to modulate the channel in a different manner. This information can be 
useful when understanding how disease mutations alter the Q1 chanel modulation and 
possibly be useful information for drug targets for modulating Q1 and its unique function 
when bound to KCNE family members. 
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Supplemental Figures 
 
 
 
 
 
Supplemental Figure 1: Specific Amino Acid Labeling of Ala 
This figure depicts the specific amino acid labeling of Ala seen in red overlay with E1FTL→TVG. Of the 7 Ala 
residues in the sequence, 6 can be seen in this figure. 
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Supplemental Figure 2:  Specific Amino Acid Labeling of Leu 
This figure depicts the spectra of single amino acid labeling of Leu. Of the 13 residues in the E1FTL→TVG 
sequence, all 13 peaks can be seen in red. 
  67 
 
 
Supplemental Figure 3: Specific Amino Acid Labeling of Phe 
This spectrum shows the specific amino acid labeling of Phe in red overlay with the E1FTL→TVG spectrum. 
Of the 5 residues in E1FTL→TVG sequence, all 5 can be observed. 
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Supplemental Figure 4: Specific Amino Acid Labeling of Met 
This figure depicts the single amino acid labeling of Met shown in the red peaks overlay with E1FTL→TVG 
spectrum. Of the 4 residues in the sequence, all 4 peaks can be observed. 
  69 
 
 
Supplemental Figure 5: Specific Amino Acid Labeling of Ile 
This figure depicts the spectrum of the specific amino acid Ile seen in red that is overlayed onto 
E1FTL→TVG. Of the 5 residues in the E1FTL→TVG sequence, only 4 were visible in this spectrum.  
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Supplemental Figure 6: T1 and T2 of E1FTL→TVG Decay Curves 
The top panel shows the decay of a single peak from 2D TROSY spectra at various T1 tau times. The 
bottom panel displays the T2 decay curve of a single point from the 2D TROSY over the T2 tau times. 
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Supplemental Figure 7: E1FTL→TVG Spectrum of Y74C Mutation 
This figure depicts the 2D TROSY spectrum of E1FTL→TVG with Y74C mutation at 50°C on a 600 MHz 
spectrometer. 
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Supplemental Figure 8: E1FTL→TVG Spectrum of Y65C Mutation 
This figure depicts the 2D TROSY spectrum of E1FTL→TVG with Y65C mutation at 50°C on a 600 MHz 
spectrometer. 
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Supplemental Figure 9: E1FTL→TVG Spectrum of S64C Mutation 
This figure depicts the 2D TROSY spectrum of E1FTL→TVG with S64C mutation at 50°C on a 600 MHz 
spectrometer. 
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Supplemental Figure 10: E1FTL→TVG Spectrum of Y46C Mutation 
This figure depicts the 2D TROSY spectrum of E1FTL→TVG with Y46C mutation at 50°C on a 600 MHz 
spectrometer. 
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Supplemental Figure 11: E1FTL→TVG Spectrum of A44C Mutation 
This figure depicts the 2D TROSY spectrum of E1FTL→TVG with A44C mutation at 50°C on a 600 MHz 
spectrometer. 
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